DWA
EVOK

Dorsey Wright & Associates’s Evoke Pharma EVOK Stock Holding History

Dorsey Wright & Associates’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11
Closed -$8K – 337
2020
Q3 		$8K Buy
+11
New +$7.02K ﹤0.01% 234

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Dorsey Wright & Associates's EVOK Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of Evoke Pharma (EVOK) in Q4 2020, closing a stake of 11 shares — an estimated $8K sold.

Dorsey Wright & Associates first reported a position in EVOK in Q3 2020 and held it in 1 quarter. The position peaked at $8K in Q3 2020. 30 funds tracked by Wall St. Rank hold EVOK as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining Evoke Pharma position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 11 Evoke Pharma shares in Q4 2020, an estimated $8K.
  • Dorsey Wright & Associates first reported a position in Evoke Pharma in Q3 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Evoke Pharma position peaked at $8K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.